N.K.A. van Eijkelenburg MD publications

foto

Publications MD N.K.A. van Eijkelenburg

Position
Medical Specialist
Main activities
Research
Specialisation
Pediatric Oncology - Clinical Pharmacology
Focus of research

Phase I/II clinical trials in Pediatric Oncology and Clinical Pharmacology in Pediatric Oncology

2020

  • Nijstad A. Laura, van Eijkelenburg Natasha K. A., Kraal Kathelijne C. J. M., Meijs Marieke J. M., de Kanter Clara T. M. M., Lilien Marc R., Huitema Alwin D. R. Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis Cancer chemotherapy and pharmacology 2020;86 (3):445-449 [PubMed]
  • Rubio-San-Simón Alba, André Nicolas, Cefalo Maria Giuseppina, Aerts Isabelle, Castañeda Alicia, Benezech Sarah, Makin Guy, van Eijkelenburg Natasha, Nysom Karsten, Marshall Lynley, Gambart Marion, Hladun Raquel, Rossig Claudia, Bergamaschi Luca, Fagioli Franca, Carpenter Ben, Ducassou Stephane, Owens Cormac, Øra Ingrid, Ribelles Antonio Juan, de Wilde Bram, Guerra-García Pilar, Strullu Marion, Rizzari Carmelo, Ek Torben, Hettmer Simone, Gerber Nicolas U., Rawlings Christine, Diezi Manuel, Palmu Sauli, Ruggiero Antonio, Verdú Jaime, de Rojas Teresa, Vassal Gilles, Geoerger Birgit, Moreno Lucas, Bautista Francisco Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium European journal of cancer (Oxford, England 2020;141:82-91 [PubMed]
  • Rensen Niki, Steur Lindsay M. H., Grootenhuis Martha A., van Eijkelenburg Natasha K. A., van der Sluis Inge M., Dors Natasja, van den Bos Cor, Tissing Wim J. E., Kaspers Gertjan J. L., van Litsenburg Raphaële R. L. Parental functioning during maintenance treatment for childhood acute lymphoblastic leukemia: Effects of treatment intensity and dexamethasone pulses Pediatric blood & cancer 2020;67 (11) [PubMed]

2019

  • Kloos Robin Q. H., Pieters Rob, van den Bos Cor, van Eijkelenburg Natasha K. A., de Jonge Robert, van der Sluis Inge M. The effect of asparaginase therapy on methotrexate toxicity and efficacy in children with acute lymphoblastic leukemia Leukemia & lymphoma 2019;60 (12):3002-3010 [PubMed]

2017

  • van Egmond P. S. , van Eijkelenburg Natasha K. A., Zwaan C. M., Mathot Ronald A. A. Evaluatie van doseerrichtlijnen en populatiefarmaco-kinetiek van vancomycine bij kinderen met kanker Pharmaceutisch Weekblad 2017;152 (46):21-24
  • Kraal K. C. J. M., Bleeker G. M., van Eck-Smit B. L. F., van Eijkelenburg N. K. A., Berthold F., van Noesel M. M., Caron H. N., Tytgat G. A. M. Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients European journal of cancer (Oxford, England 2017;76:188-196 [PubMed]
  • Postema Floor A. M., Hopman Saskia M. J., de Borgie Corianne A. J. M., Hammond Peter, Hennekam Raoul C., Merks Johannes H. M., Aalfs Cora M., Anninga Jakob K., Berger Lieke Pv, Bleeker Fonnet E., de Bont Eveline Sjm, Dommering Charlotte J., van Eijkelenburg Natasha Ka, van den Heuvel-Eibrink Marry M., Jongmans Marjolijn Cj, Kors Wijnanda A., Letteboer Tom Gw, Loeffen Jan Lcm, Olderode-Berends Maran Jw, Wagner Anja Validation of a clinical screening instrument for tumour predisposition syndromes in patients with childhood cancer (TuPS): protocol for a prospective, observational, multicentre study BMJ open 2017;7 (1):e013237 [PubMed]

2014

  • Sanders Stefan J. W. J., Bijleveld Yuma A., Sinkeler Fleur, Kemper Elles M., Pajkrt Dasja, van de Wetering Marianne, van Eijkelenburg Natasha K. A., Mathôt Ron A. A. Clinical evaluation of vancomycin dosage in pediatric oncology patients Pediatric infectious disease journal 2014;33 (7):731-733 [PubMed]
  • van Hasselt J. G. Coen, van Eijkelenburg Natasha K. A., Beijnen Jos H., Schellens Jan H. M., Huitema Alwin D. R. Design of a drug-drug interaction study of vincristine with azole antifungals in pediatric cancer patients using clinical trial simulation Pediatric blood & cancer 2014;61 (12):2223-2229 [PubMed]

2013

  • van Hasselt Johan G. C., van Eijkelenburg Natasha K. A., Beijnen Jos H., Schellens Jan H. M., Huitema Alwin D. R. Optimizing drug development of anti-cancer drugs in children using modelling and simulation British journal of clinical pharmacology 2013;76 (1):30-47 [PubMed]
  • van Hasselt Johan G. C., van Eijkelenburg Natasha K. A., Huitema Alwin D. R., Schellens Jan H. M., Schouten-van Meeteren Antoinette Y. N. Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate Antimicrobial agents and chemotherapy 2013;57 (6):2878-2881 [PubMed]

2007

  • Frakking F. N. J., Brouwer N., van Eijkelenburg N. K. A., Merkus M. P., Kuijpers T. W., Offringa M., Dolman K. M. Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis Clinical and experimental immunology 2007;150 (2):255-262 [PubMed]

2004

  • Hack W. W. M., van Eijkelenburg N. K. A. Diagnose in beeld (194). Een jongen met een doorzichtige zwelling op de glans Nederlands tijdschrift voor geneeskunde 2004;148 (25):1235 [PubMed]